Figure 7: Endometrial stem cells labeled by BrdU (a). Cultures were treated with FLX and labeled with BrdU. They were then stained with antibodies against BrdU and nestin, followed by either rhodamine- (for BrdU, red) or FITC- (nestin, green) labeled secondary antibodies (b). Data are representative of 3 independent experiments.